Clinical utility of the prognostic nomograms
CRC
The decision curve analyses were conducted to determine the clinical utility of the nomograms by quantifying the net benefits at different threshold probabilities. The decision curves for the nomogram in the training set indicated that when the threshold probabilities of the OS and DFS prediction were in the range of 10%-70% (Fig. Collectively, the decision curve showed that the prediction ability of the nomograms was superior to the TNM and AJCC staging for patients with stage II/III CRC, which supported their favorable clinical utility in predicting OS and DFS.